Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial

Patricia Pautier, Antoîne Italiano, Sophie Piperno‐Neumann, Christine Chevreau, Nicolas Penel, Nelly Firmin, Pascaline Boudou‐Rouquette, François Bertucci, Corinne Balleyguier, Valérie Lebrun-Ly, Isabelle Ray‐Coquard, Elsa Kalbacher, A. Bardet, Emmanuelle Bompas, Olivier Collard, Nicolás Isambert, Cécile Guillemet, María Rios, Baptiste Archambaud, Florence Duffaud, Antoîne Italiano, Patricia Pautier, A. Lecesne, Sophie Piperno‐Neumann, Christine Chevreau, Didier Cupissol, Nicolas Penel, Jérôme Alexandre, François Bertucci, Isabelle Ray‐Coquard, Valérie Lebrun-Ly, Elsa Kalbacher, Florence Duffaud, Corinne Delcambre, Emmanuelle Bompas, Olivier Collard, Nicolás Isambert, Cécile Guillemet, P Soulié, María Rios, Esma Saâda-Bouzid